These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37800627)

  • 21. Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.
    Hubert M; Guivel-Benhassine F; Bruel T; Porrot F; Planas D; Vanhomwegen J; Wiedemann A; Burrel S; Marot S; Palich R; Monsel G; Diombera H; Gallien S; Lopez-Zaragoza JL; Vindrios W; Taieb F; Fernandes-Pellerin S; Delhaye M; Laude H; Arowas L; Ungeheuer MN; Hocqueloux L; Pourcher V; Prazuck T; Marcelin AG; Lelièvre JD; Batéjat C; Lévy Y; Manuguerra JC; Schwartz O
    Cell Host Microbe; 2023 Jun; 31(6):937-948.e4. PubMed ID: 37196656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Multi-Epitope Universal mRNA Vaccine Candidate for Monkeypox, Smallpox, and Vaccinia Viruses: Design and In Silico Analyses.
    Rcheulishvili N; Mao J; Papukashvili D; Feng S; Liu C; Yang X; Lin J; He Y; Wang PG
    Viruses; 2023 May; 15(5):. PubMed ID: 37243206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals.
    Zaeck LM; Lamers MM; Verstrepen BE; Bestebroer TM; van Royen ME; Götz H; Shamier MC; van Leeuwen LPM; Schmitz KS; Alblas K; van Efferen S; Bogers S; Scherbeijn S; Rimmelzwaan GF; van Gorp ECM; Koopmans MPG; Haagmans BL; GeurtsvanKessel CH; de Vries RD
    Nat Med; 2023 Jan; 29(1):270-278. PubMed ID: 36257333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population.
    Li M; Guo Y; Deng Y; Gao W; Huang B; Yao W; Zhao Y; Zhang Q; Huang M; Liu M; Li L; Guo P; Tian J; Wang X; Lin Y; Gan J; Guo Y; Hu Y; Zhang J; Yang X; Shang B; Yang M; Han Y; Wang Y; Cong P; Li M; Chu Q; Zhang D; Wang Q; Zhang T; Wu G; Tan W; Gao GF; Liu J
    Cell Rep; 2024 Jan; 43(1):113609. PubMed ID: 38159277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid and highly potent humoral responses to mpox nanovaccine candidates adjuvanted by thermostable scaffolds.
    Yan H; Peng Y; Zhang J; Peng R; Feng X; Su J; Yi H; Lu Y; Gao S; Liu J; Yang M; Liu X; Gao S; Chen Z
    Vaccine; 2024 Mar; 42(8):2072-2080. PubMed ID: 38423815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans.
    Grifoni A; Zhang Y; Tarke A; Sidney J; Rubiro P; Reina-Campos M; Filaci G; Dan JM; Scheuermann RH; Sette A
    Cell Host Microbe; 2022 Dec; 30(12):1662-1670.e4. PubMed ID: 36463861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Quadrivalent mRNA Immunization Elicits Potent Immune Responses against Multiple Orthopoxviral Antigens and Neutralization of Monkeypox Virus in Rodent Models.
    Su C; Li S; Wen Y; Geng X; Yin Q; Wang Y; Xiong Y; Liu Z
    Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus.
    Wang H; Yin P; Zheng T; Qin L; Li S; Han P; Qu X; Wen J; Ding H; Wu J; Kong T; Gao Z; Hu S; Zhao X; Cao X; Fang M; Qi J; Xi JJ; Duan K; Yang X; Zhang Z; Wang Q; Tan W; Gao GF
    Nat Immunol; 2024 Feb; 25(2):307-315. PubMed ID: 38182667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population.
    Feng Y; Zhang Y; Liu S; Guo M; Huang H; Guo C; Wang W; Zhang W; Tang H; Wan Y
    BMC Med; 2023 May; 21(1):183. PubMed ID: 37189197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced Immune Responses in Mice by Combining the Mpox Virus B6R-Protein and Aluminum Hydroxide-CpG Vaccine Adjuvants.
    Li J; Li X; Dong J; Wei J; Guo X; Wang G; Xu M; Zhao A
    Vaccines (Basel); 2024 Jul; 12(7):. PubMed ID: 39066415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
    Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults.
    Morino E; Mine S; Tomita N; Uemura Y; Shimizu Y; Saito S; Suzuki T; Okumura N; Iwasaki H; Terada J; Ainai A; Sakai Y; Park E; Seki S; Akazawa D; Shimojima M; Shiwa-Sudo N; Virhuez-Mendoza M; Miyauchi K; Moriyama S; Iwata-Yoshikawa N; Harada M; Harada S; Hishiki T; Kotaki R; Matsumura T; Miyamoto S; Kanno T; Isogawa M; Watashi K; Nagata N; Ebihara H; Takahashi Y; Maeda K; Matano T; Wakita T; Suzuki T; Sugiura W; Ohmagari N; Ujiie M
    NEJM Evid; 2024 Mar; 3(3):EVIDoa2300290. PubMed ID: 38411447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of seroprevalence and kinetics of humoral response using mpox virus A29 protein.
    Cai JP; Chu WM; Tam AR; Wang K; Han Y; Chen LL; Zhang X; Choi CY; Cheng VC; Chan KH; Chen Z; Hung IF; Fong CH; To KK
    Commun Med (Lond); 2023 Nov; 3(1):168. PubMed ID: 37993690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening, Expression and Identification of Nanobody Against Monkeypox Virus A35R.
    Meng N; Cheng X; Sun M; Zhang Y; Sun X; Liu X; Chen J
    Int J Nanomedicine; 2023; 18():7173-7181. PubMed ID: 38076734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examination of the cross-reactivity between vaccinia virus Tiantan strain and monkeypox virus.
    Huang Q; Wang Y; Zhao T; Wang Y; Wang X; Li S; Su W; Ren X; Zhang X; Liu J; Wei J
    J Virol Methods; 2023 Oct; 320():114772. PubMed ID: 37473582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico development of a novel anti-mutation, multi-epitope mRNA vaccine against MPXV variants of emerging lineage and sub-lineages by using immunoinformatics approaches.
    Tan C; Zhou J; Wu A; Li C
    J Biomol Struct Dyn; 2024 Mar; ():1-18. PubMed ID: 38450722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of multi-epitope vaccines against the monkeypox virus based on envelope proteins using immunoinformatics approaches.
    Tan C; Zhu F; Pan P; Wu A; Li C
    Front Immunol; 2023; 14():1112816. PubMed ID: 36993967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategy of developing nucleic acid-based universal monkeypox vaccine candidates.
    Papukashvili D; Rcheulishvili N; Liu C; Wang X; He Y; Wang PG
    Front Immunol; 2022; 13():1050309. PubMed ID: 36389680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of neutralizing antibodies against monkeypox virus using high-throughput sequencing of A35
    Hou R; Jiang Q; Cheng M; Dai J; Yang H; Yuan J; Li X; Tang X; Yu H
    Virus Res; 2024 Sep; 347():199437. PubMed ID: 39002567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.